<DOC>
	<DOCNO>NCT02344719</DOCNO>
	<brief_summary>The investigator want analyze effect Taurin portal hemodynamics patient advance liver cirrhosis .</brief_summary>
	<brief_title>Effect Taurine Portal Hemodynamics Patients With Advanced Liver Cirrhosis</brief_title>
	<detailed_description>28 day 6 gram Taurine versus Placebo ( randomization 1:1 ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>Patients ( male female ) age old 18 year advance liver cirrhosis ( Child 's Grade B Child 's Grade C ) , regardless disease origin ( viral , alcoholic , idiopathic ) , schedule hepatic hemodynamic investigation Negative pregnancy test woman childbearing potential Patient without beta blocker therapy : due : intolerance medication , preexist contraindication beta blocker therapy , endoscopic band ligation prophylaxis History variceal bleed without endoscopic band ligation History endoscopically diagnose large varix red spot without previous bleed without endoscopic band ligation HVPG &lt; 10 mmHg HVPG &gt; 20 mmHg varix , unless ligate treated eradication program within 6 month Beta Blocker therapy History hypersensitivity trial drug contrast agent drug similar chemical structure Treatment vasoactive nonsteroidal antiinflammatory drug systematic antibiotic one week study Exclusion criterion hepatic hemodynamic investigation Cardiac , renal respiratory failure Previous surgical transjugular intrahepatic portosystemic shunt Breastfeeding pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>portal hypertension</keyword>
	<keyword>taurin</keyword>
</DOC>